Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC148 antisense RNA 1 (CCDC148-AS1) is a long non-coding RNA (lncRNA) located on chromosome 11 and is approximately 1,500 nucleotides in length[2]. It is classified as an antisense RNA, meaning it is complementary to the mRNA of the CCDC148 gene, and it does not encode a protein[2][3]. CCDC148-AS1 is expressed in several tissues, including the brain, heart, and liver, and interacts with RNA-binding proteins such as hnRNPK, suggesting a regulatory role[2]. Although its precise biological function remains largely uncharacterized, CCDC148-AS1 is implicated in the regulation of gene expression at the transcriptional, post-transcriptional, and possibly epigenetic levels, with roles suggested in controlling cell proliferation, apoptosis, and migration[2]. Like other antisense lncRNAs, it could potentially be involved in cancer-related pathways; however, specific disease associations or therapeutic targeting of CCDC148-AS1 have not been definitively established[4][2][3]. No drugs, biomarkers, or specific safety concerns related to CCDC148-AS1 are currently known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCDC148 antisense RNA 1 (CCDC148-AS1).